Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 32

Trial Status

Completed1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT02824354Phase 3Withdrawn
Nalmefene in Patients With Alcoholic Compensated Cirrhosis for the Treatment of Alcohol Dependence.
Alcohol DependenceCirrhosisNalmefene
PrincipalinvestigatorStart date: 2018-12-01
NCT03069131Phase 3Completed
Two Strategies of Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Severe Cirrhotic Patients With Ascites
AscitesCirrhosisPeritonitis
PrincipalinvestigatorStart date: 2018-06-05

Research Network

Collaboration Network

20 collaborators·54 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

CHU Amiens

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Rodolphe Anty, MD

Centre Hospitalier Universitaire de Nice

Moderately Similar
2 trials

Shared therapeutic areas:

AscitesCirrhosisPeritonitis

Worked with same sponsors:

Alfasigma S.p.A.Centre Hospitalier Universitaire de Besancon+1 more
Collaborated on 1 trial
Similarity Score34%

Frédéric Oberti, MD

University Hospital, Angers

Moderately Similar
1 trials

Shared therapeutic areas:

AscitesCirrhosisPeritonitis

Worked with same sponsors:

Alfasigma S.p.A.Centre Hospitalier Universitaire de Besancon+1 more
Collaborated on 1 trial
Similarity Score34%

Isabelle Rosa-Hezode, MD

CHIC de Créteil

Moderately Similar
1 trials

Shared therapeutic areas:

AscitesCirrhosisPeritonitis

Worked with same sponsors:

Alfasigma S.p.A.Centre Hospitalier Universitaire de Besancon+1 more
Collaborated on 1 trial
Similarity Score34%

Alexandre Louvet, MD, PhD

CHRU de Lille

Moderately Similar
1 trials

Shared therapeutic areas:

AscitesCirrhosisPeritonitis

Worked with same sponsors:

Alfasigma S.p.A.Centre Hospitalier Universitaire de Besancon+1 more
Collaborated on 1 trial
Similarity Score34%

Pierre Nahon, MD, PhD

Hôpital Jean Verdier, Bondy

Moderately Similar
1 trials

Shared therapeutic areas:

AscitesCirrhosisPeritonitis

Worked with same sponsors:

Alfasigma S.p.A.Centre Hospitalier Universitaire de Besancon+1 more
Collaborated on 1 trial
Similarity Score34%

Marianne Latournerie, MD

Centre Hospitalier Universitaire Dijon

Moderately Similar
1 trials

Shared therapeutic areas:

AscitesCirrhosisPeritonitis

Worked with same sponsors:

Alfasigma S.p.A.Centre Hospitalier Universitaire de Besancon+1 more
Collaborated on 1 trial
Similarity Score34%

Vincent Di Martino, MD, PhD

CHRU de Besançon

Moderately Similar
1 trials

Shared therapeutic areas:

AscitesCirrhosisPeritonitis

Worked with same sponsors:

Alfasigma S.p.A.Centre Hospitalier Universitaire de Besancon+1 more
Collaborated on 1 trial
Similarity Score34%

Laure Elkrief, MD

CHU Tours

Moderately Similar
1 trials

Shared therapeutic areas:

AscitesCirrhosisPeritonitis

Worked with same sponsors:

Alfasigma S.p.A.Centre Hospitalier Universitaire de Besancon+1 more
Collaborated on 1 trial
Similarity Score34%

Matthieu Schnee, MD

Hôpital La Roche-sur-Yon

Moderately Similar
1 trials

Shared therapeutic areas:

AscitesCirrhosisPeritonitis

Worked with same sponsors:

Alfasigma S.p.A.Centre Hospitalier Universitaire de Besancon+1 more
Collaborated on 1 trial
Similarity Score34%

Ghassan Riachi, MD

CHU Rouen

Moderately Similar
1 trials

Shared therapeutic areas:

AscitesCirrhosisPeritonitis

Worked with same sponsors:

Alfasigma S.p.A.Centre Hospitalier Universitaire de Besancon+1 more
Collaborated on 1 trial
Similarity Score34%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT02824354Phase 3PrincipalInvestigator

Nalmefene in Patients With Alcoholic Compensated Cirrhosis for the Treatment of Alcohol Dependence.

Alcohol DependenceCirrhosisNalmefene
Withdrawn
NCT03069131Phase 3PrincipalInvestigator

Two Strategies of Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Severe Cirrhotic Patients With Ascites

AscitesCirrhosisPeritonitis
Completed

All 2 trials loaded